Marvel Biosciences Insider Trading
TSX-V MRVL
2
All Trades
0
Significant
1
Notable
0
Clusters
0
Repeat
Healthcare
Sector
Biotechnology
Industry
$10.1M
Market Cap
0.12 – 0.29
52 Week Range
45K
Avg. Volume
| Company | Insider | Title | Tr. Date | Fi. Date | Shares | Price | Value | Balance | Increase | Signal |
|---|---|---|---|---|---|---|---|---|---|---|
| Marvel Biosciences | Matheson, Joseph | CEO | 14-Aug-26 | 14-Aug-26 | 7,076,358 | MN | ||||
| Marvel Biosciences | Matheson, Joseph | CEO | 20-Jun-25 | 20-Jun-25 | 1,607,049 | NT |
Marvel Biosciences (MRVL): Insider trading △ Insider buy
Volume (thousands)
Related Companies to Explore
Company Info
Marvel Biosciences Corp. is a Canadian biotechnology company focused on developing synthetic chemical derivatives of existing approved drugs for new disease indications. The company’s lead compound, MB-204, is a novel fluorinated derivative of istradefylline, a drug that acts as an adenosine A2a receptor antagonist. MB-204 is being developed to address Alzheimer’s disease, autism spectrum disorder, depression, and anxiety. In addition to its lead compound program, the company offers a non-hallucinogenic neuroplasticity program. Marvel Biosciences operates within the healthcare sector and is headquartered in Calgary, Canada.
Don’t miss today’s trades
Full access to real-time insider buying data — $8.25/mo, billed annually. Cancel anytime.